Story perspectives
Congress Tackles High Drug Costs Amid Rising Premiums
2/11/2026
1 of 1
Story summary
- Most Americans face high prescription drug costs, prompting Congress to pursue solutions that lower prices and increase market competition.
- Blue Cross and Blue Shield Plans say rising premiums stem from higher medical care costs, not insurer practices, and back CivicaScript as bipartisan efforts to enhance competition continue.
- U.S. President Donald Trump has proposed 'most favored nation' pricing to align drug costs with international levels, though some Republicans remain skeptical.
